KIMES 2024

NAMSA invites you to join us at KIMES 2024 on March 14-17 in Seoul, Korea. Discover the future of the medical industry and stay abreast of the latest trends at KIMES, a unique platform where 1,200 manufacturers from around the world showcase new technologies and products. This exhibition offers an unparalleled opportunity to recognize the immense potential and prospects within the medical field. Join us for a dynamic exchange of the latest medical information and technologies, ensuring you stay ahead in the rapidly evolving medical market.

NAMSA will be participating in the KIMES exhibition in collaboration with KMDA. Join us for an insightful speaker session titled “Common Steps for Bringing a Clinical Stage SaMD AI/ML Product to Market” featuring expert speaker Monica Montanez, Principal Regulatory Consultant.

Don’t miss this opportunity to gain valuable insights into the essential steps for bringing a Clinical Stage SaMD AI/ML product to market. Mark your calendar and be part of this informative session at the KIMES exhibition. We look forward to sharing knowledge and connecting with you at this exciting event!

Speaker

Monica Montanez, Principal Regulatory Consultant

With over two decades of experience in the medical device industry, Monica Montañez has carved a distinguished career path. From her early roles at Millar Instruments to prominent positions at Cyberonics, CONMED, and Medtronic, she has amassed a wealth of experience. Joining NAMSA in 2010, Monica transitioned into consultancy, emerging as an in-house expert in regulatory software and artificial intelligence. Holding a Master’s of Science in Regulatory Science from the University of Southern California, Monica’s competencies span various domains, including cardiovascular, orthopedic, wearables, and IoT. Her recent successes involve securing FDA approvals for innovative devices, such as a software-only digital therapeutic device and a Liver Machine Perfusion system. With a knack for establishing robust SOPs and navigating the intricacies of SDLC requirements, Monica continues to be a valuable force in the evolving landscape of medical device regulations.